CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study
==============================================================================================================================================================

* Aung Naing
* Fiona Thistlethwaite
* Elisabeth G.E. De Vries
* Ferry A.L.M. Eskens
* Nataliya Uboha
* Patrick A. Ott
* Patricia LoRusso
* Javier Garcia-Corbacho
* Valentina Boni
* Johanna Bendell
* Karen A. Autio
* Manreet Randhawa
* Greg Durm
* Marta Gil-Martin
* Mark Stroh
* Alison L. Hannah
* Hendrik-Tobias Arkenau
* Alexander Spira